Seeking Alpha

Momenta Pharmaceuticals (MNTA) says partner Sandoz confirmed the launch of a generic version of...

Momenta Pharmaceuticals (MNTA) says partner Sandoz confirmed the launch of a generic version of its Lovenox blood thinner under an agreement that features a hybrid royalty-profit sharing plan. MNTA -10.5% premarket.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs